ArticleNature communications2016

Targeting dendritic cells to accelerate T-cell activation overcomes a bottleneck in tuberculosis vaccine efficacy.

Kristin L Griffiths et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.